Imricor Medical Systems, Inc. (ASX:IMR)
Australia · Delayed Price · Currency is AUD 1.365
+0.030 (2.25%)
Aug 14, 2025, 4:10 PM AEST
Imricor Medical Systems Market Cap
Imricor Medical Systems has a market cap or net worth of 427.80 million as of August 14, 2025. Its market cap has increased by 192.25% in one year.
Market Cap
427.80M
Enterprise Value
436.69M
Revenue
1.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.37
Market Cap Chart
Since August 30, 2019, Imricor Medical Systems's market cap has increased from 87.01M to 427.80M, an increase of 391.66%. That is a compound annual growth rate of 30.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 437.41M | 19.04% |
| Dec 31, 2024 | 367.44M | 281.62% |
| Dec 29, 2023 | 96.28M | 74.29% |
| Dec 30, 2022 | 55.24M | -61.62% |
| Dec 31, 2021 | 143.95M | -49.27% |
| Dec 31, 2020 | 283.74M | 155.25% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 127.74B |
| Pro Medicus | 31.84B |
| Cochlear | 20.37B |
| Sonic Healthcare | 13.62B |
| Ramsay Health Care | 8.91B |
| Telix Pharmaceuticals | 5.72B |
| Ansell | 4.52B |
| Mesoblast | 2.93B |